FDA Commissioner Nominee Henney Asked To Justify RU-486 Review
Executive Summary
FDA Commissioner nominee Jane Henney's response to Congressional questions about the RU-486 review will likely take the form of a general statement that the agency should not solicit applications where a social controversy exists.